UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
PTPI holding history
Petros Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTPI overviewAll 13F holders of PTPIFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −119,072−100.0% | Sold out | Holders |
| Q1 2025 | 119,072 | $8.22K | <0.1% | +106,080+816.5% | Added | Holders |
| Q4 2024 | 12,992 | $5.12K | <0.1% | −31,229−70.6% | Reduced | Holders |
| Q3 2024 | 44,221 | $15.8K | <0.1% | +44,221 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −1,098−100.0% | Sold out | Holders |
| Q4 2022 | 1,098 | $2.56K | <0.1% | +1,098 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −4,820−100.0% | Sold out | Holders |
| Q1 2022 | 4,820 | $8.00K | <0.1% | +2,771+135.2% | Added | Holders |
| Q4 2021 | 2,049 | $7.00K | <0.1% | −1,563−43.3% | Reduced | Holders |
| Q3 2021 | 3,612 | $7.00K | <0.1% | +2,669+283.0% | Added | Holders |
| Q2 2021 | 943 | $3.00K | <0.1% | +943 | New | Holders |